• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

由黏液瘤性二尖瓣疾病引起肺动脉高压犬的血管周围炎症细胞及其与肺血管重构的关系。

Perivascular inflammatory cells and their association with pulmonary arterial remodelling in dogs with pulmonary hypertension due to myxomatous mitral valve disease.

机构信息

Department of Veterinary Medicine, Faculty of Veterinary Science, Chulalongkorn University, Bangkok, 10330, Thailand.

Companion Animal Cancer Research Unit, Department of Veterinary Pathology, Faculty of Veterinary Science, Chulalongkorn University, Bangkok, 10330, Thailand.

出版信息

Vet Res Commun. 2023 Sep;47(3):1505-1521. doi: 10.1007/s11259-023-10106-0. Epub 2023 Mar 28.

DOI:10.1007/s11259-023-10106-0
PMID:36976445
Abstract

Pulmonary hypertension (PH), an increase in pulmonary arterial pressure (PAP), may occur in dogs affected with myxomatous mitral valve disease (MMVD). Recent studies suggest that an accumulation of perivascular inflammatory cells may be involved with medial thickening which is a sign of the pulmonary artery remodelling in PH. The aim of this study was to characterise perivascular inflammatory cells in the surrounding pulmonary arteries of dogs with PH due to MMVD compared to MMVD dogs and healthy control dogs. Nineteen lung samples were collected from cadavers of small-breed dogs (control n = 5; MMVD n = 7; MMVD + PH n = 7). Toluidine blue stain and multiple IHC targeting α-SMA, vWF, CD20, CD68 and CD3 was performed to examine intimal and medial thickening, assess muscularisation of the small pulmonary arteries and characterise perivascular leucocytes. Medial thickening without intimal thickening of pulmonary arteries and muscularisation of normally non-muscularised small pulmonary arteries was observed in the MMVD and MMVD + PH groups compared with the control group. The perivascular numbers of B lymphocytes, T lymphocytes and macrophages was significantly increased in the MMVD + PH group compared with the MMVD and control groups. In contrast, the perivascular number of mast cells was significantly higher in the MMVD group compared with the MMVD + PH and control groups. This study suggested that pulmonary artery remodelling as medial thickening and muscularisation of the normally non-muscular small pulmonary arteries is accompanied by the accumulation of perivascular inflammatory cells.

摘要

肺动脉高压(PH)是指肺动脉压力(PAP)升高,可能发生在患有黏液瘤性二尖瓣疾病(MMVD)的犬中。最近的研究表明,血管周围炎症细胞的积累可能与中膜增厚有关,中膜增厚是 PH 中肺动脉重塑的标志。本研究旨在比较 MMVD 伴 PH 犬与 MMVD 犬和健康对照犬的 PH 犬周围肺小动脉中血管周围炎症细胞的特征。从小型犬尸体中收集了 19 个肺样本(对照组 n=5;MMVD 组 n=7;MMVD+PH 组 n=7)。使用甲苯胺蓝染色和针对α-SMA、vWF、CD20、CD68 和 CD3 的多重免疫组化染色,检查内膜和中膜增厚,评估小肺动脉的肌化,并对血管周围白细胞进行特征描述。与对照组相比,MMVD 组和 MMVD+PH 组的肺小动脉出现中膜增厚而无内膜增厚,且正常非肌化的小肺动脉发生肌化。与 MMVD 组和对照组相比,MMVD+PH 组的血管周围 B 淋巴细胞、T 淋巴细胞和巨噬细胞数量明显增加。相比之下,MMVD 组的血管周围肥大细胞数量明显高于 MMVD+PH 组和对照组。本研究表明,肺小动脉重塑表现为中膜增厚和正常非肌化小肺动脉的肌化,同时伴有血管周围炎症细胞的积累。

相似文献

1
Perivascular inflammatory cells and their association with pulmonary arterial remodelling in dogs with pulmonary hypertension due to myxomatous mitral valve disease.由黏液瘤性二尖瓣疾病引起肺动脉高压犬的血管周围炎症细胞及其与肺血管重构的关系。
Vet Res Commun. 2023 Sep;47(3):1505-1521. doi: 10.1007/s11259-023-10106-0. Epub 2023 Mar 28.
2
The prevalence of pulmonary hypertension in Cavalier King Charles spaniels compared with other breeds with myxomatous mitral valve disease.与患有黏液瘤性二尖瓣疾病的其他犬种相比,查理士王小猎犬肺动脉高压的患病率。
J Vet Cardiol. 2019 Jun;23:21-31. doi: 10.1016/j.jvc.2019.01.002. Epub 2019 Feb 23.
3
Myxomatous mitral valve disease and associated pulmonary hypertension might increase serum angiopoietin-2 in dogs.黏液瘤样二尖瓣疾病及相关肺动脉高压可能会使犬血清血管生成素-2升高。
Am J Vet Res. 2024 Mar 30;85(6). doi: 10.2460/ajvr.23.12.0289. Print 2024 Jun 1.
4
Prognostic value of pulmonary vascular resistance estimated by echocardiography in dogs with myxomatous mitral valve disease and pulmonary hypertension.超声心动图估测肺血管阻力对黏液瘤性二尖瓣疾病伴肺动脉高压犬的预后价值。
J Vet Intern Med. 2023 May-Jun;37(3):856-865. doi: 10.1111/jvim.16686. Epub 2023 Mar 30.
5
Tricuspid annular plane systolic excursion in dogs with myxomatous mitral valve disease with and without pulmonary hypertension.患有或不患有肺动脉高压的黏液瘤样二尖瓣疾病犬的三尖瓣环平面收缩期位移
J Vet Cardiol. 2017 Jun;19(3):228-239. doi: 10.1016/j.jvc.2017.03.007. Epub 2017 Jun 2.
6
Platelet hyperresponsiveness and increased platelet-neutrophil aggregates in dogs with myxomatous mitral valve disease and pulmonary hypertension.黏液样变性二尖瓣疾病和肺动脉高压犬的血小板高反应性和血小板-中性粒细胞聚集体增加。
J Vet Intern Med. 2024 Jul-Aug;38(4):2052-2063. doi: 10.1111/jvim.17067. Epub 2024 May 21.
7
Serotonin concentrations in platelets, plasma, mitral valve leaflet, and left ventricular myocardial tissue in dogs with myxomatous mitral valve disease.患有黏液瘤样二尖瓣疾病的犬类血小板、血浆、二尖瓣小叶及左心室心肌组织中的血清素浓度。
J Vet Intern Med. 2014 Sep-Oct;28(5):1534-40. doi: 10.1111/jvim.12420. Epub 2014 Aug 21.
8
Iron parameters analysis in dogs with myxomatous mitral valve disease.犬黏液瘤性二尖瓣疾病的铁参数分析。
BMC Vet Res. 2024 May 18;20(1):210. doi: 10.1186/s12917-024-04071-2.
9
Proteomics reveals plasma protein SERPINH1 as a potential diagnostic biomarkers for myxomatous mitral valve disease stage B2.蛋白质组学揭示血浆蛋白 SERPINH1 作为黏液样二尖瓣病变 B2 期的潜在诊断生物标志物。
J Proteomics. 2023 Jun 30;282:104924. doi: 10.1016/j.jprot.2023.104924. Epub 2023 May 3.
10
Proteomic analysis of the serum in dogs with pulmonary hypertension secondary to myxomatous mitral valve disease: the preliminary study.黏液瘤样二尖瓣疾病继发肺动脉高压犬血清的蛋白质组学分析:初步研究
Front Vet Sci. 2024 Mar 26;11:1327453. doi: 10.3389/fvets.2024.1327453. eCollection 2024.

引用本文的文献

1
Involvement of TGF-β, mTOR, and inflammatory mediators in aging alterations during myxomatous mitral valve disease in a canine model.犬粘液瘤样二尖瓣疾病衰老改变中转化生长因子-β、雷帕霉素靶蛋白及炎症介质的作用
Geroscience. 2025 Jan 27. doi: 10.1007/s11357-025-01520-0.

本文引用的文献

1
Histopathological changes of pulmonary vascular remodeling in dogs affected with pulmonary hypertension secondary to degenerative mitral valve disease.患有退行性二尖瓣疾病继发肺动脉高压的犬类肺血管重塑的组织病理学变化。
J Vet Cardiol. 2021 Aug;36:141-152. doi: 10.1016/j.jvc.2021.06.005. Epub 2021 Jun 24.
2
Endothelial Dysfunction in Pulmonary Hypertension: Cause or Consequence?肺动脉高压中的内皮功能障碍:原因还是结果?
Biomedicines. 2021 Jan 9;9(1):57. doi: 10.3390/biomedicines9010057.
3
Perivascular Inflammation in Pulmonary Arterial Hypertension.
肺高血压中的血管周围炎症。
Cells. 2020 Oct 22;9(11):2338. doi: 10.3390/cells9112338.
4
The role of macrophages in pulmonary hypertension: Pathogenesis and targeting.巨噬细胞在肺动脉高压中的作用:发病机制与靶向治疗。
Int Immunopharmacol. 2020 Nov;88:106934. doi: 10.1016/j.intimp.2020.106934. Epub 2020 Sep 2.
5
ACVIM consensus statement guidelines for the diagnosis, classification, treatment, and monitoring of pulmonary hypertension in dogs.ACVIM 共识声明指南:犬肺动脉高压的诊断、分类、治疗和监测。
J Vet Intern Med. 2020 Mar;34(2):549-573. doi: 10.1111/jvim.15725. Epub 2020 Feb 17.
6
Immunoglobulin-driven Complement Activation Regulates Proinflammatory Remodeling in Pulmonary Hypertension.免疫球蛋白驱动的补体激活调节肺动脉高压中的促炎重塑。
Am J Respir Crit Care Med. 2020 Jan 15;201(2):224-239. doi: 10.1164/rccm.201903-0591OC.
7
CCR2/CCR5-mediated macrophage-smooth muscle cell crosstalk in pulmonary hypertension.CCR2/CCR5 介导的肺动脉高压中巨噬细胞-平滑肌细胞串扰。
Eur Respir J. 2019 Oct 10;54(4). doi: 10.1183/13993003.02308-2018. Print 2019 Oct.
8
ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs.ACVIM 共识指南:犬黏液瘤性二尖瓣疾病的诊断与治疗。
J Vet Intern Med. 2019 May;33(3):1127-1140. doi: 10.1111/jvim.15488. Epub 2019 Apr 11.
9
Pulmonary arterial remodelling by deficiency of peroxisome proliferator-activated receptor-γ in murine vascular smooth muscle cells occurs independently of obesity-related pulmonary hypertension.在肥胖相关肺动脉高压以外,过氧化物酶体增殖物激活受体-γ 缺陷导致的肺动脉平滑肌细胞重塑在小鼠中发生。
Respir Res. 2019 Feb 27;20(1):42. doi: 10.1186/s12931-019-1003-4.
10
Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives.肺动脉高压的病理学和病理生物学:现状和研究展望。
Eur Respir J. 2019 Jan 24;53(1). doi: 10.1183/13993003.01887-2018. Print 2019 Jan.